Markets:

Overview

News

Currencies

International

Treasuries

Rhelion Life Sciences Corp (OP:TRUFF)

0.0220 -0.0020 (-8.33%)

Streaming Delayed Price Updated: 11:20 AM EDT, Aug 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Rhelion Life Sciences Corp

< Previous 1 2 3 Next >

Kala Bio Celebrates Trump Executive Order as Game-Changer for Psychedelic Medicine

April 21, 2026

Historic U.S. Executive Order Fast-Tracks Psychedelic Research Access; Landmark Policy Shift Strengthens the Outlook for KALA’s Client Red Light Holland and Positions Researgency.ai as the Dedicated AI...

From KALA BIO, Inc.

Via GlobeNewswire

$180 Billion AI Healthcare Emerging Sector Highlighted by Red Light Holland’s Researgency.ai Platform for Biotech & Pharmaceutical Industry: KALA BIO, Inc. (Nasdaq: KALA)

March 19, 2026

Via Get News

Topics Artificial Intelligence Intellectual Property

Red Light Holland Engages Kala Bio’s Researgency.AI Platform to Support Clinical Development of Filament’s Patented PEX010 Botanical Psilocybin Drug Candidate

March 18, 2026

From KALA BIO, Inc.

Via GlobeNewswire

Red Light Holland's Wholly Owned Subsidiary Happy Caps Mushroom Farm Secures Continued Safeway Partnership to 123 Stores Across Two Seasonal Programs in the U.S.

September 04, 2025

Toronto, Ontario--(Newsfile Corp. - September 4, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light...

Via Newsfile

Red Light Holland Q2 Revenue Up 39.1% YoY, Cuts Net Loss Thanks To 'Strong Financial Discipline' ↗

December 02, 2024

Via Benzinga

PharmAla Biotech Partners With Johns Hopkins University For MDMA Clinical Trials, Terminates Red Light Holland Contract ↗

September 11, 2024

PharmAla Biotech partners with Johns Hopkins to supply MDMA for clinical trials, terminates contract with Red Light Holland, and presents new APA-01 research at the EBPS Workshop.

Via Benzinga

Red Light Holland Q1 Revenue Spikes Nearly 30% YoY, Focuses On Strategic Profitability ↗

August 30, 2024

Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) announced on Thursday its financial and operational results for the first quarter of fiscal 2025, three months ending June 30, 2024. The...

Via Benzinga

EXCLUSIVE: Legal Magic Mushroom Products Will Be Sold In Jamaica As Psilocybin Products Hit Pharmacy Shelves ↗

July 31, 2024

Jamaica introduces its first legal psilocybin products in pharmacies through a historic partnership between PATOO and Fontana Pharmacy.

Via Benzinga

Red Light Holland Reports 20.3% Revenue Growth YoY, Remains 'Strategically Focused On The Long Game' ↗

July 30, 2024

Via Benzinga

Canadian Biotech Duo Hits Psilocybin Extraction Milestone For API Development At Scale ↗

May 29, 2024

Red Light Holland and PharmAla achieve psilocybin extraction milestone, advancing API development for scalable medical products. Read now!

Via Benzinga

Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans' Trips And More ↗

April 17, 2024

Via Benzinga

Psychedelics Headlines: A Form Of Life, Treating Chronic Pain, Microdosing And More ↗

March 30, 2024

Via Benzinga

Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And More ↗

March 20, 2024

Via Benzinga

Topics Economy

Truffles To Market: Red Light Holland Wants To Develop Psilocybin API At Scale ↗

March 11, 2024

Via Benzinga

Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More ↗

March 04, 2024

Via Benzinga

Psychedelics Headlines: Trauma-Informed Care, Valentine's Day & MDMA, Academics On Drugs And More ↗

February 15, 2024

Via Benzinga

Psyched: Defense Dept.'s Ketamine Trial, Cybin's Psilocybin, Metabolic Disorders, Reform Update And More ↗

December 05, 2023

Defense Dept. Funds Ketamine Study For PTSD Treatment

Via Benzinga

Braxia Scientific's Q2 2024: Cash Burn Over But Income Low, What's Next For Psychedelics Company? ↗

December 04, 2023

Ontario-based Canadian psychedelics company Braxia Scientific Corp. (OTC Pink: BRAXF) filed its interim financial statements and management discussion for the three and six months ended Sept. 30,...

Via Benzinga

Red Light Holland, With $12M Cash Balance & Revenue Up 33%, Remains 'Confident' In Business Strategy ↗

November 29, 2023

Canada-based all-mushroom producer Red Light Holland Corp. (OTCQB: TRUFF) filed its quarterly financial statements and management discussion and analysis for the three and six months ended Sept. 30,...

Via Benzinga

Psyched: Cybin's Center Stage In Novel Psychedelics, Musk & Ramaswamy, Britney's Memoirs And More ↗

October 29, 2023

Cybin Officially Owns Small Pharma, Gets Three New International Patents Granted

Via Benzinga

Topics Intellectual Property

U.S. Patent For 3D Movement Data Goes To Red Light Holland Subsidiary, More AI Innovation Ahead ↗

October 20, 2023

Canadian mushrooms producer Red Light Holland’s (OTCQB: TRUFF) wholly-owned tech subsidiary Radix Motion received a U.S.

Via Benzinga

Topics Artificial Intelligence Intellectual Property

From Fast-Acting Hemp Extracts To Wiz Khalifa Mushroom Kits: Tracking Progressive Trends In Cannabis & Psychedelics ↗

September 22, 2023

The world of cannabis and psychedelics is evolving at a rapid pace, with companies introducing groundbreaking products and expanding into new markets.

Via Benzinga

Topics Cannabis

Grow Your Own Organic Mushrooms With Wiz Khalifa's Growing Kits ↗

September 20, 2023

Ontario-based mushrooms producer Red Light Holland Corp.

Via Benzinga

Psyched: Three Noteworthy Psychedelics M&As, Colorado's Regulations, Exclusive Financing & More ↗

September 05, 2023

Cybin's Acquisition Of Small Pharma Will Elevate DMT Therapeutics For Depression And Anxiety

Via Benzinga

Red Light Holland's Q1 2024 Performance: Revenue Soars 53% And Solid Cash Balance ↗

August 29, 2023

Ontario-based mushrooms producer Red Light Holland Corp. (OTCQB: TRUFF) filed its quarterly financial statements, management discussion and analysis for the three months ended June 30. The Numbers:

Via Benzinga

Psyched: Psilocybin For Gambling Addiction, Ex-NHL Player's Retreat, Fellini's LSD Creativity, Surveys, Financing & More ↗

August 28, 2023

Psilocybin Therapy Trials: Gambling Addiction Study, Opioid Pain & Alcohol Addiction Trials

Via Benzinga

Red Light Holland Psilocybin Microdosing Capsules Pass 8 Weeks Of Stability Testing ↗

August 22, 2023

Red Light Holland Corp.

Via Benzinga

Psyched: Professional Practice Guidelines, DMT For Stroke, Dua Lipa &. Amanda Feilding, Clinical Results & More ↗

August 14, 2023

First Ever Professional Practice Guidelines For Psychedelic-Assisted Therapy Published

Via Benzinga

Natural Psilocybin Companies Diversify: Latest By Optimi, Red Light Holland And A European Player ↗

August 01, 2023

Optimi Completes Novel Extraction Process and Files U.S. Prov. Patent

Via Benzinga

Increased Production & Retail Sales For Magic Truffles: Red Light Holland Balances 2023 Financial Results ↗

July 31, 2023

Ontario-based all-mushrooms producer Red Light Holland Corp. (OTCQB: TRUFF) filed its audited annual financial statements, plus management takes and analysis, for the financial years ended March 31,...

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Rhelion Life Sciences Corp (OP:TRUFF)

All News about Rhelion Life Sciences Corp

Starting at /week.